Search Results1-5 of  5

  • INOMATA Hyoe ID: 9000004092136

    International Medical Center of Japan, Research Institute (2007 from CiNii)

    Articles in CiNii:9

    • Identification of Quantitative Trait Loci for Cardiac Hypertrophy in Two Different Strains of the Spontaneously Hypertensive Rat (2005)
    • Evaluation of genetic susceptibility for cardiac hypertrophy with relation to hypertension, sexual dimorphism, and genetic make-up (2002)
    • OE-287 Comprehensive investigation of quantitative trait loci for blood pressure and associated metabolic traits in the spontaneous hypertensive rat strains(Genetics/Genetically Engineered Models 2 (H) : OE36)(Oral Presentation (English)) (2004)
  • Inomata Hyoe ID: 9000386133950

    Amgen Astellas BioPharma K. K. (2018 from CiNii)

    Articles in CiNii:1

    • Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy (2018)
  • Inomata Hyoe ID: 9000391664110

    Amgen Astellas BioPharma K.K. (2017 from CiNii)

    Articles in CiNii:1

    • One-Year Efficacy and Safety of Evolocumab in Japanese Patients ― A Pooled Analysis From the Open-Label Extension OSLER Studies ― (2017)
  • Inomata Hyoe ID: 9000402387568

    Amgen Astellas BioPharma K.K. (2019 from CiNii)

    Articles in CiNii:1

    • Long-Term Treatment With Evolocumab Among Japanese Patients ― Final Report of the OSLER Open-Label Extension Studies ― (2019)
  • Inomata Hyoe ID: 9000402461983

    Amgen Astellas BioPharma K.K. (2019 from CiNii)

    Articles in CiNii:1

    • 12-Week Effectiveness and Safety of Low-Density Lipoprotein Cholesterol-Lowering Therapy by Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition in Patients With Familial Hypercholesterolemia and Hypercholesterolemia ― Data From a Real-World Observational Study of Evolocumab in Japan ― (2019)
Page Top